Syndax Pharmaceuticals Inc - Common Stock (SNDX)

CUSIP: 87164F105

Q3 2021 13F Holders as of 30 Sep 2021

Type / Class
Equity / Common Stock
Shares outstanding
86,727,396
Total 13F shares
49,078,197
Share change
-1,134,374
Total reported value
$938,007,416
Put/Call ratio
54%
Price per share
$19.11
Number of holders
121
Value change
-$20,732,602
Number of buys
55
Number of sells
51

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 87164F105?
CUSIP 87164F105 identifies SNDX - Syndax Pharmaceuticals Inc - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of SNDX - Syndax Pharmaceuticals Inc - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Avidity Partners Management LP
13F
Company
5.3%
4,615,000
$79,240,000 30 Jun 2021
13F
BlackRock Finance, Inc.
13F
Company
4.1%
3,519,894
$60,436,000 30 Jun 2021
13F
STATE STREET CORP
13F
Company
3.7%
3,170,432
$54,436,000 30 Jun 2021
13F
Avoro Capital Advisors LLC
13F
Company
3.5%
3,000,000
$51,510,000 30 Jun 2021
13F
Nantahala Capital Management, LLC
13F
Company
3%
2,593,337
$44,528,000 30 Jun 2021
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
2.9%
2,491,272
$42,775,000 30 Jun 2021
13F
BVF INC/IL
13F
Company
2.9%
2,486,429
$42,692,000 30 Jun 2021
13F
Boxer Capital, LLC
13F
Company
2.6%
2,287,782
$39,281,000 30 Jun 2021
13F
PFM Health Sciences, LP
13F
Company
2.5%
2,144,881
$36,828,000 30 Jun 2021
13F
VANGUARD GROUP INC
13F
Company
2.4%
2,108,748
$36,207,000 30 Jun 2021
13F
CITADEL ADVISORS LLC
13F
Company
2.3%
1,958,631
$33,630,000 30 Jun 2021
13F
HealthCor Management, L.P.
13F
Company
2%
1,751,342
$30,071,000 30 Jun 2021
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
1.9%
1,635,931
$28,089,000 30 Jun 2021
13F
Casdin Capital, LLC
13F
Company
1.4%
1,200,000
$20,604,000 30 Jun 2021
13F
FRAZIER MANAGEMENT LLC
13F
Company
1.4%
1,188,135
$20,400,000 30 Jun 2021
13F
683 Capital Management, LLC
13F
Company
1.3%
1,085,900
$18,644,000 30 Jun 2021
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.2%
1,076,768
$18,488,000 30 Jun 2021
13F
Aisling Capital Management LP
13F
Company
1.2%
1,025,000
$17,599,000 30 Jun 2021
13F
Ghost Tree Capital, LLC
13F
Company
1%
875,000
$15,024,000 30 Jun 2021
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.82%
706,942
$12,138,000 30 Jun 2021
13F
EVENTIDE ASSET MANAGEMENT, LLC
13F
Company
0.81%
702,348
$12,059,000 30 Jun 2021
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.63%
547,187
$9,395,000 30 Jun 2021
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.58%
501,798
$8,616,000 30 Jun 2021
13F
NORTHERN TRUST CORP
13F
Company
0.53%
458,909
$7,879,000 30 Jun 2021
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.49%
428,452
$7,357,000 30 Jun 2021
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.48%
420,420
$7,219,000 30 Jun 2021
13F
D. E. Shaw & Co., Inc.
13F
Company
0.47%
410,467
$7,048,000 30 Jun 2021
13F
Palo Alto Investors LP
13F
Company
0.46%
401,100
$6,887,000 30 Jun 2021
13F
Vivo Capital, LLC
13F
Company
0.37%
320,000
$5,494,000 30 Jun 2021
13F
Point72 Asset Management, L.P.
13F
Company
0.36%
312,400
$5,364,000 30 Jun 2021
13F
LORD, ABBETT & CO. LLC
13F
Company
0.34%
294,609
$5,058,000 30 Jun 2021
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.31%
269,631
$4,630,000 30 Jun 2021
13F
Nuveen Asset Management, LLC
13F
Company
0.25%
216,914
$3,725,000 30 Jun 2021
13F
CITIGROUP INC
13F
Company
0.25%
213,360
$3,663,000 30 Jun 2021
13F
Woodline Partners LP
13F
Company
0.24%
207,812
$3,568,000 30 Jun 2021
13F
ACUTA CAPITAL PARTNERS, LLC
13F
Company
0.24%
206,126
$3,539,000 30 Jun 2021
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.24%
206,001
$3,537,000 30 Jun 2021
13F
PUTNAM INVESTMENTS LLC
13F
Company
0.24%
205,040
$3,521,000 30 Jun 2021
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.24%
203,845
$3,500,000 30 Jun 2021
13F
MACQUARIE GROUP LTD
13F
Company
0.21%
180,991
$3,108,000 30 Jun 2021
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.2%
173,086
$2,973,000 30 Jun 2021
13F
DAFNA Capital Management LLC
13F
Company
0.17%
147,702
$2,536,000 30 Jun 2021
13F
Bank of New York Mellon Corp
13F
Company
0.17%
146,945
$2,524,000 30 Jun 2021
13F
Rafferty Asset Management, LLC
13F
Company
0.16%
138,172
$2,372,000 30 Jun 2021
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.14%
119,401
$2,050,000 30 Jun 2021
13F
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND
13F
Company
0.13%
117,000
$2,009,000 30 Jun 2021
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.13%
112,339
$1,929,000 30 Jun 2021
13F
Phoenix Financial Ltd.
13F
Company
0.13%
110,000
$1,889,000 30 Jun 2021
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.12%
107,858
$1,852,000 30 Jun 2021
13F
Swiss National Bank
13F
Company
0.1%
83,100
$1,427,000 30 Jun 2021
13F

Institutional Holders of Syndax Pharmaceuticals Inc - Common Stock (SNDX) as of Q3 2021

As of 30 Sep 2021, Syndax Pharmaceuticals Inc - Common Stock (SNDX) was held by 121 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 49,078,197 shares. The largest 10 holders included Avidity Partners Management LP, BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., Nantahala Capital Management, LLC, BVF INC/IL, BOXER CAPITAL, LLC, VANGUARD GROUP INC, STATE STREET CORP, PFM Health Sciences, LP, and CITADEL ADVISORS LLC. This page lists 121 institutional shareholders reporting positions in this security for the Q3 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2021 vs Q2 2021 Across Filers

Q2 2021 holders
113
Q3 2021 holders
121
Holder diff
8
Investor Q2 2021 Shares Q3 2021 Shares Share Diff Share Chg % Q2 2021 Value $ Q3 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.